Logo
x

Search

Subscribe Now

Kyowa Kirin

Kyowa Kirin to Acquire Orchard Therapeutics for ~$477.6M

Kyowa Kirin to Acquire Orchard Therapeutics for ~$477.6M

  • October 5, 2023
Kyowa Kirin and MEI Pharma Reports P-II (MIRAGE) Study Results of Zandelisib for Indolent B-cell Non-Hodgkin’s Lymphoma in Japan

Kyowa Kirin and MEI Pharma Reports P-II (MIRAGE) Study Results of Zandelisib for Indolent B-cell Non-Hodgkin’s Lymphoma in Japan

  • November 21, 2022
PharmaShots Interview: Abdul Mullick, CEO at Kyowa Kirin Shares Insights on the Launch of a Virtual Exhibition to Highlight Issues of Rare Disease, X-linked Hypophosphataemia

PharmaShots Interview: Abdul Mullick, CEO at Kyowa Kirin Shares Insights on the Launch of a Virtual Exhibition to Highlight Issues...

  • July 27, 2022
PharmaShots Weekly Snapshots (May 31 - June 4, 2021)

PharmaShots Weekly Snapshots (May 31 - June 4, 2021)

  • June 4, 2021
Insights+ Key Biosimilars Events of June 2020

Insights+ Key Biosimilars Events of June 2020

  • July 3, 2020
PharmaShots Weekly Snapshot (Jun 15-19, 2020)

PharmaShots Weekly Snapshot (Jun 15-19, 2020)

  • June 22, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.